Working on behalf of the Welsh life science sector, MediWales creates business opportunities and partnerships for our members, supports global trade development, improves access to vital clinical expertise and engages with government to align support with sector needs. We recognise and celebrate our members’ success and promote the strengths of the sector within Wales.
MediWales can provide one to one referrals to partners across the academic, business and clinical communities and offer advice on technology adoption, procurement and clinical trials.
Access to clinical expertise is an essential part of the product development process for medical devices and pharmaceuticals.
We work closely with NHS trusts and health boards, as well as academic and clinical research centres to facilitate collaboration across the NHS and industry.
It is important that MediWales represents the interests of its members. Active representation to both UK and Welsh Governments provides an independent voice for the life science sector in Wales.
Our programme of Special Interest Groups, events and Advisory Board meetings helps our team to maintain a thorough understanding of current issues and to ensure that the needs of our members are conveyed to policymakers and support organisations in a timely and collaborative manner.
MediWales maintains regular contact through email, meetings, events and online, with well over 6,000 named contacts. Our team regularly conducts surveys and consultations with our members to ensure that we are up to date with what is going on in the life science sector, including new companies, mergers and acquisitions, new research studies and trials, and support available for innovation and trade.
Our Advisory Forum and Special Interest Groups give our members the opportunity to discuss and express their needs and concerns.
MediWales publishes reports and market data through our website and publications and at events.
Our most valuable sources of market intelligence are the regular one to one meetings we have with each of our members.
The life science sector is a global industry. Whether marketing medical devices, developing new drugs and diagnostics or manufacturing pharmaceuticals, our members’ markets are international.
Our team regularly attend international trade events, such as Medica in Dusseldorf, Arab Health in Dubai and Bio-Europe events across Europe, to promote our members’ products and services, build international relationships, and gain first-hand experience of which events and markets present the best opportunities for our members.
High quality communication is essential for a network to operate effectively. By constantly facilitating the exchange of information and offering promotional opportunities to our members, we provide a variety of avenues to choose from to showcase their success and developments, and find new collaborative partners.
Our popular events programme provides excellent networking and business development opportunities for our members.
We work hard to recognise and showcase the achievements of our members. One of our most highly regarded pathways for recognition is our annual Innovation Awards competition. With ten awards across industry and NHS categories, the awards offer a platform to identify outstanding achievements in the life science sector in Wales.
The life sciences sector is continually changing and therefore must adapt and capitalise on its strengths in order to compete in a challenging environment.
The ultimate success of the Life Sciences Industrial Strategy is closely tied to the ability to train and recruit the best possible workforce, equipped with a breadth of critical skills. Having technical expertise is vital and there is increasing demand for entrepreneurial skills with commercial experience that can help grow our life sciences sector.
MediWales recognises the need for the development of and access to skills within the sector. Targeting the skills agenda is a priority for us to aid our members’ growth and development. We are increasing our focus on recruitment, student placements and continued professional development through our LifeScience Academy activity.
